Roundup of articles and publications on the latest innovations in malaria, polio, lymphatic filariasis, and onchocerciasis

13 May 2024 – Below we feature a compilation of headlines, scientific articles, and technical reports on innovations, R&D and elimination progress towards polio, malaria, onchocerciasis, and lymphatic filariasis. We will be publishing these updates bi-weekly and hope they are useful.

 

Diagnostic testing and treatment

• New antibiotic against river blindness and lymphatic filariasis pathogens – Link

Immunisation

• United against Polio: nationwide polio vaccination campaign kicks off in Liberia – Link
• Three West African countries begin vaccinating against malaria – Link

Elimination progress

• Polio eradication initiative – Link
• GPEI delegation visits Pakistan to discuss strategies to eradicate polio with Government of Pakistan – Link
• Factors associated with never treatment and acceptability of mass drug administration for the elimination of lymphatic filariasis in Guyana, 2021 – Link

Climate and Health

• Needs and opportunities for addressing the nexus of climate change and public health in Africa – Link

Other

• Financial hardship among patients suffering from neglected tropical diseases: A systematic review and meta-analysis of global literature – Link
• Global report on neglected tropical diseases 2024 – Link
• FDA’s proposed rule and its regulatory impact on emerging and reemerging neglected tropical diseases in the United States – Link
• Onchocerciasis in the Cameroon–Chad border area after more than 20 years of annual mass ivermectin distribution – Link
• Onchocerciasis-associated epilepsy and biomarkers – Link
• Combating Neglected Tropical Diseases in Liberia: nearly 2 million people to benefit from Mass Drug Administration against lymphatic filariasis and schistosomiasis in endemic counties – Link
• Colombia launches national plan for the elimination and eradication of communicable diseases – Link
• Predictive immunoinformatics reveal promising safety and anti-Onchocerciasis protective immune response profiles to vaccine candidates (Ov-RAL-2 and Ov-103) in anticipation of phase I clinical trials – Link
• Active infection with Onchocerca volvulus and the linkage to epilepsy/nodding syndrome – Link
• Enhancing capacity for malaria vaccine introduction and rollout in Africa through experience sharing – Link
• Towards understanding the microepidemiology of Lymphatic Filariasis at the community level in Ghana – Link
• Leveraging malaria vaccines and mRNA technology to tackle the global inequity in pharmaceutical research and production towards disease elimination – Link
• Albumin levels in malaria patients: a systematic review and meta-analysis of their association with disease severity – Link 
• Immune targeting of filarial glutaredoxin through a multi-epitope peptide-based vaccine: A reverse vaccinology approach – Link
• The effects of selected neglected tropical diseases on economic performance at the macrolevel in Africa – Link

 

Please contact us with comments and feedback.